我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
14
14 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
尚未招募
100.0%
暂无批准数据
- A randomized, double-blind, placebo-controlled trial evaluated Bacillus coagulans LMG S-31876 (ProBC Plus) on immune function and stress in 50 subjects with immune and stress-related ailments. - Results showed ProBC Plus significantly improved immune status and aided in stress relief compared to the placebo group over the eight-week study period (p < 0.05). - ProBC Plus also exhibited potential cardiovascular support by helping maintain lipid profiles within normal ranges, with vital signs remaining stable throughout the trial. - The study suggests ProBC Plus is safe for consumption and supports overall well-being by positively influencing immune response, stress levels, and lipid parameters.